Sino-Israel Fund Management

The firm targets early-stage and growth-stage opportunities — seed, venture, and growth — with a focus on cross-border technology transfer between China and Israel. It typically makes direct equity investments in companies where Israeli innovation can benefit from Chinese scale in manufacturing, distribution, or capital markets.

Based on public record and the firm's stated strategy, sector focus includes cybersecurity, agricultural technology (AgriTech), digital health, enterprise software, and related technology verticals where China-Israel synergies are most pronounced.

The firm likely leverages networks in both China and Israel — including relationships with Israeli incubators, universities, venture capital firms, and Chinese industrial partners — to identify proprietary deal flow. Cross-border technology transfer deals require strong local presence in both markets, though specific sourcing partnerships are not publicly documented.

Sino-Israel Fund Management operates as a private equity asset manager, not a family office. Its structure appears to be a traditional PE fund vehicle, raising capital from institutional and accredited investors, though exact fund vehicles and investor bases are not publicly disclosed.

The firm makes direct equity investments in portfolio companies, targeting seed, venture, and growth stages. It does not appear to operate as a fund-of-funds or primarily allocate to external managers, based on its public positioning as a private equity manager.

The firm's headquarters is in Dalian, China. No additional offices have been publicly confirmed, though cross-border operations with Israel are central to its strategy.

As of mid-2026, no named principals or team members have been publicly identified in media reports or official filings. The firm's investment committee, leadership structure, and professional staff remain undisclosed — a limitation of private firm reporting.